Company Snapshot
- Ticker
- HSIC
- Name
- HSIC
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 9204237118.900000
- Volume
- 1,099,543
- Avg Volume (3M)
- 1,553,839
Interactive chart with SMA overlays and intraday breadth.
Plot valuation, momentum, or volume trends.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X Read more
Curated headlines from premium sources.
Arrowstreet Capital Limited Partnership grew its stake in Henry Schein, Inc. (NASDAQ: HSIC) by 80.7% during the undefined quarter, according to its most recent…
Henry Schein stands out as the largest global provider of healthcare products and services for office-based dental and medical practitioners, with a strong mar…
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclus…